Avigan maker gets hometown help to secure scarce key ingredient

Toyama Prefecture will fund companies that produce A11 as China halts exports

20200407N Fujifilm Toyama

Fujifilm Toyama Chemical developed the flu drug Avigan, which was approved for use in 2014. (Photo courtesy of Fujifilm Toyama Chemical)

TAKUJI KUNISHIDA, Nikkei staff writer

TOYAMA, Japan -- The maker of Avigan is slated to receive local government help in accessing a critical ingredient, a goal in line with Japanese plans to stockpile the flu drug showing promise against the novel coronavirus.

Sponsored Content

About Sponsored ContentThis content was commissioned by Nikkei's Global Business Bureau.